World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: RPCEC
Last refreshed on: 29 April 2013
Main ID:  RPCEC00000094
Date of registration: 01/03/2010
Primary sponsor: Municipality of Public Health, Plaza.
Public title: Lidoment - pain osteomioarticular - phase IV
Scientific title: Lidoment, analgesic medicamental formulation for relief of the pain in the system osteomioarticular.
Date of first enrolment: 30/06/2007
Target sample size: 200
Recruitment status: Closed
URL:  http://registroclinico.sld.cu/trials/RPCEC00000094-En
Study type:  Interventional
Study design:  Randomization: N/A: single arm study. Blinding: Open. Placebo: Uncontrolled Assignment: Single Group Purpose: Treatment  
Countries of recruitment
Cuba
Contacts
Name: Malena  Zelada Pérez
Address:  15th. street,corner at 18, Vedado. 10400 Havana City Cuba
Telephone: 5378356773
Email: mzelada@infomed.sld.cu
Affiliation:  Vedado Policlinical
Name: Malena  Zelada Pérez
Address:  15th. street,corner at 18, Vedado. 10400 Havana City Cuba
Telephone: 5378356773
Email: mzelada@infomed.sld.cu
Affiliation:  Vedado Policlinical
Key inclusion & exclusion criteria
Inclusion criteria: 1.Patient of any age, sex and ethnic group that are remitted by the specialist in Anesthesiology, of the service of integral Rehabilitation of the Vedado Policlinical, payees of pains osteomioarticulars, which were remitted to their consultation to be valued and treaties. 2.The patients' consent to participate in the trial, included in the pattern of clinical history of the pain made for the same ones.
Exclusion criteria: a.Patients that presented some pathology like: sepsis in the affected area, oncological processes, bigger psychiatric dysfunctions and/or cerebral damage. b.The negative of the patients of participating in the investigation.

Age minimum: 18 years
Age maximum: 80 years
Gender: Both
Health Condition(s) or Problem(s) studied
Pain
Intervention(s)
Daily topical application of the analgesic gel, during 7 days. The formulation contains the mixture of Lidocaine 5% - 30 ml and Menthol 1%.
Primary Outcome(s)
Pain (analogue pain scale,0-10, 0 is no pain and 10 is the worst imaginable pain). Measurement time: Daily by the patient, 7 days after begining the treatment by the doctor.
Secondary Outcome(s)
Osteomioarticular system lesions (description of lesions). Measurement time: 7 days after begining the treatment.
Secondary ID(s)
Source(s) of Monetary Support
Ministry of Public Health, Cuba.
Secondary Sponsor(s)
Ministry of Public Health. Cuba.
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history